nevertheless infectious, as they can be acquired by larval ticks that feed upon treated 1 mice (xenodiagnosis), and survive molting into nymphal ticks. Nymphal ticks can then 2 effectively transmit spirochetes to naïve mice, which develop disseminated infection. At 3 all phases of these events, spirochetes cannot be cultured, and their numbers are very 4 low, suggesting a viable but slowly-or non-dividing population (27) . These features fit 5 the paradigm of multidrug tolerance or "recalcitrance to eradication" by antibiotics that 6 occurs among a variety of persistent bacterial and fungal infections (reviewed in (30, 38 , 7
39)). 8
These results challenge prevailing dogma about effectiveness of antibiotics for 9 eliminating B. burgdorferi infection, and therefore further work is critically needed. The 10 purpose of the present study was to test the potential for improved effectiveness of a 11 new first in class antibiotic, tigecycline (glycylcycline) (21), which has been shown to be 12 highly active and bactericidal in vitro against multiple strains of B. burgdorferi (81) 13 compared to previously published treatment regimens of ceftriaxone, a beta-lactam 14 antibiotic which is similarly highly active and bactericidal in vitro (40) and has become 15 the mainstay in the treatment of disseminated and chronic Lyme disease (78). In the 16 current study, antibiotics were administered during the early dissemination (1 week), 17 early immune (3 weeks), or late (4 months) stages of B. burgdorferi infection in 18 immunocompetent C3H mice to mimic the stages found in human disease. 19 
20

MATERIALS AND METHODS 21
Mice. Five-week old female C3H/HeN (C3H) mice were purchased from the 22 were specific pathogen free, and maintained in an isolation room under static filter-top 25 cages and provided food and water ad libitum. Mice were necropsied following an 26
American Veterinary Medical Association approved euthanasia procedure of carbon 27 dioxide narcosis and exsanguination by cardiocentesis. The presence of infectious 28 spirochetes in tissues of various treated mice was assessed by subcutaneous 29 transplantation of small pieces of tibiotarsal joint and heart base tissue into recipient 30 SCID mice under ketamine/xylazine anesthesia, as described (6, 8) . Animal were examined under darkfield microscopy. MIC was the lowest concentration of 31 antibiotic at which the number of cells after incubation did not exceed the initial 32 concentration. The Minimum Bactericidal Concentration (MBC) was the lowest antibiotic 1 concentration from which spirochetes could not be cultured after 72 h of co-incubation 2 with antibiotics. Following 72 h of incubation with antibiotic, an aliquot (20 µL) from 3 each test well was transferred to 5 mL of fresh BSK-H medium and subcultures were 4 assessed for the presence of motile spirochetes at 21 days. 5
Ticks. Ticks were derived from a single population of laboratory-reared Ixodes 6 scapularis larvae kindly provided by Durland Fish of Yale University. For 7 xenodiagnosis, 40 larval ticks were placed on mice at 1 week prior to necropsy and 8 allowed to feed to repletion. Engorged larvae were allowed to molt into nymphs and 9
harden, and samples of each tick cohort from each mouse were individually tested by 10 ospA PCR to determine the prevalence of infection within each cohort. Ten nymphal 11 ticks from positive cohorts were allowed to attach and feed upon naïve SCID mice to 12 determine presence of infective spirochetes. Some of the nymphs were allowed to molt 13 into adult ticks, which were then dipped in 70% ethanol and bisected sagittally using a 14 sterilized razor blade. One half of the tick was placed in BSK II medium containing 50 15 mg/ml rifampin, 20 mg/ml phosphomycin and 2.5 mg/ml amphotericin B, incubated at 16 33 0 C for 11-14 days, and then examined for spirochete growth under darkfield 17 microscopy. The other half of the tick was frozen in liquid nitrogen, ground with a 18 mortar and pestle and DNA was extracted for PCR analysis. 19 PCR analysis. Quantitative real-time PCR was utilized to detect ospA DNA in 20 mouse tissues and ticks, as previously described (25, 26). The ospA target was chosen 21 because of the known "target imbalance" of ospA over other gene targets in spirochetal 22 DNA obtained from tissues (51), which has been confirmed in multiple studies in this 23 laboratory. All samples were assayed with positive and negative controls. In addition, 24 since copy numbers of target DNA are typically very low in antibiotic-treated mice, the 25 specificity of the real-time PCR was verified on skin, heart base, ventricular muscle, 26 quadriceps muscle and tibiotarsal tissues from 4 uninfected mice (20 sites total) and 27 subjected to flaB, ospA and dbpA real-time PCR amplification. All samples were 28 negative for all 3 gene targets, and 16 positive control tissues from previously archived 29 antibiotic-treated mice were positive. DNA was extracted from tissues or ticks with 30 developed, using previously published B. burgdorferi N40-specific primer sequences 5 (25). Although nested RT-PCR is not precisely quantitative, this assay was used to 6 detect RNA transcription in tissues of mice subjected to the various treatments. Total 7 RNA from each sample was purified using RNeasy mini kits, according to the 8 manufacturer's instruction for tissues (Qiagen, Valencia, CA). Samples were frozen in 9 liquid nitrogen and homogenized with a mortar and pestle (pretreated with 0.1% 10 diethylpyrocarbonate in water overnight, and then autoclaved). RNA was purified using 11 the RNeasy protocol for animal tissues. After elution, RNA was treated with RNase-free 12 DNase1, and then repurified using the RNeasy cleanup protocol. Extracted total RNA RT-PCR reactions were set up using individual sets of inner primers and labeled 25 probes. Amplification, data acquisition and data analysis were performed in an ABI 26
Prism 7700 Sequence Detector (Perkin-Elmer, Applied Biosystems, Foster City, CA). 27
Serology. Antibody titers were determined against B. burgdorferi N40 lysates by 28 enzyme linked immunosorbent assay (ELISA), using duplicate three-fold serial dilutions 29 of test serum and alkaline phosphatase-conjugated rat anti-mouse immunoglobulin 30 (heavy and light chain), as described (18, 27 mice were treated with high dose tigecycline, low dose tigecycline, ceftriaxone, or 29 saline. Saline-treated mice served as negative-effect controls and ceftriaxone-treated 30 mice served as positive-effect controls, using a previously published regimen that 31 resulted in persistence of non-cultivable spirochetes (13, 27) . Treatment was 32 commenced at 1 week, 3 weeks, or 4 months of infection. Based upon previous studies 1 in C3H mice, these stages of infection represented an early pre-immune phase of 2 infection (1 week) in which spirochetes are in the process of disseminating from the site 3 of inoculation; an early immune phase of infection (3 weeks) in which the host immune 4 response is underway and beginning to resolve joint and heart inflammation and 5 globally reducing spirochete burdens in tissues; and a late phase of infection (4 months) 6 in which inflammation is generally absent and infection is persistent (7, 9, 25). Early 7 and late stages of infection were evaluated because treatment regimens for later stage 8
Lyme disease in humans require longer and sometimes repeated courses of antibiotics 9 (68, 78). Mice were necropsied at 3 months after completion of treatment, which 10 provided an interval that would test for survival and outgrowth of spirochetes well after 11 antibiotic levels had dissipated. among heart base tissues during the early immune phase interval, heart base tissues 25 from DNA-positive samples were analyzed for RNA transcription by nested RT-PCR 26 (Table 5) . Samples were tested for flaB, ospA, ospC, arp, dbpA, bbk-32, oppA-2 and 27 mouse β actin (mouse positive control). These targets were selected because they are (oppA-2) (42, 76). Most of the samples from saline-treated mice were positive for all 32 targets (except ospA). RNA was detected variably among tissues from antibiotic-treated 1 mice, depending upon the RNA target. Notably, none of 16 samples from antibiotic-2 treated mice had detectable levels of flaB, and the most common target detected in 3 tissues from antibiotic-treated mice was oppA-2. These results indicate viability and 4 metabolic activity among the persisting spirochetes. 5
Xenodiagnosis and Transmission of Spirochetes. Xenodiagnosis was 6
performed on mice treated with high tigecycline or saline during the late persistent 7 phase of infection. Larval ticks were fed to repletion on each of the mice (one week 8 prior to necropsy), allowed to molt, and 15 to 23 nymphal ticks from mice in each of the 9 treatment groups were allowed to feed upon individual SCID mice. Two SCID mice 10 were infested with ticks from high tigecycline-treated mice and 3 SCID mice were 11 infested with ticks from saline-treated mice. None of the tissues from SCID mice fed 12 upon by ticks from antibiotic-treated mice were culture-positive, whereas all 3 of the 13 Inflammatory lesions were present in the hearts and joints of only the SCID mice fed 19 upon by ticks from the saline-treated mice. Thus, mice treated with tigecycline during 20 the late phase of infection remained infected with spirochetes that could be acquired by 21 ticks, and could be transmitted by ticks to SCID mice, but the spirochetes were present 22 in very low numbers and did not induce disease. 23
Xenodiagnosis was also performed on 8 ceftriaxone-treated mice treated during 24 the early immune phase of infection. This treatment group was selected to examine the 25 phenomenon of tick acquisition and transmission through molting into adult stage, in 26 order to confirm and extend previous studies with ceftriaxone (13, 27) . Forty larval ticks 27 were fed to repletion on each mouse (one week prior to necropsy), and allowed to molt 28 into nymphs. Cohorts of nymphs from each mouse were sampled to determine 29 acquisition of infection by the ticks, and 3 of the cohorts were found to contain PCR-30 positive ticks. Six of 7, 6 of 8, and 3 of 4 nymphs from the 3 cohorts were ospA PCR-31 positive. Copy numbers of ospA DNA ranged from 31.1 to 1,840 copies per tick. The 32 remaining nymphal ticks were pooled, and 15 nymphs were allowed to feed on each of 1 7 SCID mice. The SCID mice were necropsied at 30 days after tick feeding, and tissues 2 were cultured (skin near tick feeding sites, quadriceps muscle, heart, joint, and urinary 3 bladder) and sampled for ospA PCR reactivity (tick feeding site, ventricular muscle, 4 quadriceps muscle, joint and ear). Ticks on all 7 SCID mice fed to repletion, and were 5 collected, but 4 of the SCID mice died prior to necropsy (water bottle accident). None of 6 tissues from the remaining 3 SCID mice was culture-positive, but all tissues from the 7 SCID mice were positive for ospA DNA, ranging from 1.8 to 98 ospA copies per mg 8 tissue. These results indicated that ticks feeding upon ceftriaxone-treated mice 9 acquired infection, and transmitted infection to SCID mice, as previously shown (27) . 10
None of the mice had inflammatory lesions in their joints or hearts. 11
In an effort to determine if spirochetes from ceftriaxone-treated mice survived 12 molting from the nymphal stage into adults, the remaining nymphs that fed upon the 13 SCID mice were allowed to molt into adults. The adult ticks were bisected, and one half 14 was cultured, and the other half was assayed for ospA DNA. All 78 adult ticks were and heart base tissue from each mouse that was treated with high tigecycline, 23 ceftriaxone, or saline were transplanted subcutaneously into a single SCID mouse for 24 each treated donor mouse (Table 6 ). Previously published studies with ceftriaxone 25 revealed a very low level of transmission by tissue transplant, but those studies used 26 ear tissue, which was less apt to be persistently infected after antibiotic treatment (27) . 27
Therefore, tibiotarsal and heart base tissue from treated mice were utilized in the 28 current study, since these sites were more consistently positive after treatment. The 29 recipient SCID mice were necropsied at 4 weeks after transplantation, and blood, 30 urinary bladder and transplantation sites were cultured. None of 9 SCID mice 31 transplanted with tissue from high tigecycline-treated mice and none of 10 SCID mice 32 transplanted with tissue from ceftriaxone-treated mice were culture-positive. Four of 1 nine SCID mice that received transplants from high tigecycline treated mice had one or 2 more tissue sites that were ospA PCR positive. Four of 10 SCID mice that received 3 transplants from ceftriaxone-treated mice had single tissue sites that were ospA PCR 4 positive. Copy numbers of ospA DNA ranged from 1.2 to 18.6 copies per mg tissue. In 5 contrast, all ten SCID mice transplanted with tissues from the saline-treated mice were 6 culture positive, including 9 of 10 with bacteremia. Furthermore, all tissue sites 7 contained ospA DNA, with copy numbers ranging from 144 to 112,000 copies per mg 8 tissue. Histology of joint and heart tissue of the recipient SCID mice revealed 9 inflammation in all knees and tibiotarsal joints (arthritis) and inflammation in all hearts 10 (carditis) of mice receiving transplants from saline-treated donors, whereas there were 11 no detectable lesions in joints or hearts of SCID mice receiving transplants from mice 12 treated with ceftriaxone or high tigecycline. These results demonstrated that tissues 13 from antibiotic-treated mice contained spirochetes that were capable of infecting SCID 14 mice following transplant of tissues, and were capable of dissemination to multiple sites, 15 but they did not induce arthritis or carditis. 16 
17
DISCUSSION 18 19
The current study examined the efficacy of tigecycline, a new first in class 20 glycylcycline, which is the most potent antibiotic against B. burgdorferi on a weight basis 21 in vitro. Tigecycline is a structural analog of minocycline that avoids tetracycline 22 resistance mediated by inhibition of bacterial efflux pumps and ribosomal protection 23 (21). However, using both low and high doses of tigecycline, essentially similar findings 24 of persistence of non-cultivable, infectious spirochetes were found, as previously shown 25 with ceftriaxone and doxycycline (13, 26, 27) . Thus, the phenomenon of B. burgdorferi 26 persistence appears to be universal among these various classes of antibiotics. 27
Earlier studies on antibiotic treatment of laboratory mice that were based upon 28 culture of tissues as a read-out, showed effective elimination of infection (44), and this 29 was essentially confirmed with standard PCR assays (41). With the advent of more 30 sensitive real-time PCR, PCR-positive, culture-negative evidence for spirochete 31 persistence after antibiotic treatment has been increasingly recognized, using the 32 mouse model (13, 27, 82) . This phenomenon was originally noted in dogs treated with 1 doxycycline or amoxicillin for 30 days, in which joint disease was prevented or cured, 2 but tissues from the majority of dogs remained 23S rRNA or ospA PCR-positive, yet 3 most tissues were culture-negative (70). In a study in which mice were treated with 4 ceftriaxone or doxycycline for 30 days, persistence of non-cultivable spirochetes was 5 confirmed by xenodiagnosis, with spirochetes detected in ticks by immunoflourescence 6 and ospA PCR, but tick transmission to SCID mice did not take place. It was concluded 7 that antibiotic treatment resulted in spirochete attenuation, with loss of infectivity-8 associated plasmids (lp25 and lp28-1) (13) . That study prompted further investigation in 9 mice treated with ceftriaxone or saline at 3 weeks or 4 months of infection (27) . 10
Persisting spirochetes could be detected by PCR but not culture, and infection was 11 verified by xenodiagnosis. However, in contrast to findings of Bockenstedt, et al., ticks 12 transmitted infection to SCID mice, and BBE21.1 (lp25), arp and vlsE (lp28-1) gene 13 targets could be amplified from flaB DNA-positive tissues, indicating the presence of 14 both plasmids (26, 27) . In the present study, tick transmission to SCID mice was 15 confirmed, and spirochetes in the ticks survived molting into the adult tick stage. following antibiotic treatment. For at least 3 months after cessation of antibiotic, these 28 non-cultivable forms can be acquired by ticks (xenodiagnosis), transmitted by ticks, 29 survive the molts between larvae to nymphs to adults, infect recipient mice by tissue 30 transplant, transcribe RNA, and express antigen in ticks and tissues in the form of 31 morphologically identifiable spirochetes (13, 27) . The fact that these forms are unable 32 persistence, previous studies (13, 27) and the current study indicate that antibiotic 6 treatment results in a significant decline in antibody titers to B. burgdorferi suggesting 7 that the persisting spirochetes remain sequestered or occult to immune surveillance. 8
The significance of antibiotic persisting B. burgdorferi has also been challenged (80), 9
because no disease was evident in SCID mice infected with these organisms. That 10 conclusion is not valid, since inflammation does not necessarily correlate with presence 11 of spirochetes. Inflammation requires invasion of specific tissue types, such as 12 synovium, and no inflammation is found in many other tissues (in fact the majority) 13 infected with B. burgdorferi (9). We did not examine specific sites for the presence of B. 14 burgdorferi by microscopy, or hold the SCID mice for longer intervals to determine if 15 disease would evolve. 
